Astonea Labs Limited

₹335.00As of Sun 8 Nov 2026, 12:00 UTC
BSE:544409Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 11.95%
Pharmaceutical Preparations
Beta (5Y) —
PE TTM 74.64
TSR TTM 123.33%
Mkt cap ₹3.521B
ROIC 7.11%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹394
17.47%
(48.94%)
Hold 1|1|1|8|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
3.54
3.57
3.69
3.78
0.85%
(8.28%)
(1.15%)
2.24%
Revenue₹M
178.5
184.7
192.1
195.7
7.72%
9.79%
9.11%
13.70%
Peers (US$37.50M)
Cap (US$)
PE
52.57M
21.04x
28.77M
18.26x
37.37M
12.38x
Capital
TTM
5Y
10Y
Leveragex
2.633
—
—
EBIT/Intx
0.924
0.163
0.152
Own earn%
76.35
44.73
67.11
Sh yield%
24.48
36.50
34.24
Owners
Insiders/Inst%
5.76
44.84
Short interest%
5.54
SBC / revenue%
2.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
26–31
$1 testx
3.1
Incr. ROIC%
11